NMR Restraints Grid

Result table
 (Save to zip file containing files for each block)

image mrblock_id pdb_id bmrb_id cing stage program type
637432 6h8c 34307 cing 1-original MR format comment


*HEADER    SIGNALING PROTEIN                       02-AUG-18   6H8C              
*TITLE     STRUCTURE OF THE HUMAN GABARAPL2 PROTEIN IN COMPLEX WITH THE UBA5 LIR 
*TITLE    2 MOTIF                                                                
*COMPND    MOL_ID: 1;                                                            
*COMPND   2 MOLECULE: GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 2;
*COMPND   3 CHAIN: A;                                                            
*COMPND   4 SYNONYM: GABA(A) RECEPTOR-ASSOCIATED PROTEIN-LIKE 2,GANGLIOSIDE      
*COMPND   5 EXPRESSION FACTOR 2,GEF-2,GENERAL PROTEIN TRANSPORT FACTOR P16,GOLGI-
*COMPND   6 ASSOCIATED ATPASE ENHANCER OF 16 KDA,GATE-16,MAP1 LIGHT CHAIN 3-     
*COMPND   7 RELATED PROTEIN;                                                     
*COMPND   8 ENGINEERED: YES;                                                     
*COMPND   9 OTHER_DETAILS: GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-  
*COMPND  10 LIKE 2 (GABARAPL2) RESIDUES 3-116, RESIDUES 1-2 ARE EXPRESSING TAG;  
*COMPND  11 MOL_ID: 2;                                                           
*COMPND  12 MOLECULE: UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 5;               
*COMPND  13 CHAIN: B;                                                            
*COMPND  14 SYNONYM: UBIQUITIN-ACTIVATING ENZYME 5,THIFP1,UFM1-ACTIVATING ENZYME,
*COMPND  15 UBIQUITIN-ACTIVATING ENZYME E1 DOMAIN-CONTAINING PROTEIN 1;          
*COMPND  16 ENGINEERED: YES;                                                     
*COMPND  17 OTHER_DETAILS: UFM1-ACTIVATING ENZYME 5 (UBA5) LIR/UFIM CONTAINING   
*COMPND  18 PEPTIDE (RESIDES 333-348). FIRST 3 RESIDUES (GLY-ALA-MET) ARE        
*COMPND  19 EXPRESSION TAG.                                                      
*SOURCE    MOL_ID: 1;                                                            
*SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
*SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
*SOURCE   4 ORGANISM_TAXID: 9606;                                                
*SOURCE   5 GENE: GABARAPL2, FLC3A, GEF2;                                        
*SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;                            
*SOURCE   7 EXPRESSION_SYSTEM_TAXID: 511693;                                     
*SOURCE   8 EXPRESSION_SYSTEM_VARIANT: NEB T7 EXPRESS;                           
*SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
*SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PET39;                                    
*SOURCE  11 MOL_ID: 2;                                                           
*SOURCE  12 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
*SOURCE  13 ORGANISM_COMMON: HUMAN;                                              
*SOURCE  14 ORGANISM_TAXID: 9606;                                                
*SOURCE  15 GENE: UBA5, UBE1DC1;                                                 
*SOURCE  16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;                            
*SOURCE  17 EXPRESSION_SYSTEM_TAXID: 511693;                                     
*SOURCE  18 EXPRESSION_SYSTEM_VARIANT: NEB T7 EXPRESS;                           
*SOURCE  19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
*SOURCE  20 EXPRESSION_SYSTEM_PLASMID: PET39                                     
*KEYWDS    GABARAPL2, UBA5 LIR MOTIF, PROTEIN COMPLEX, SIGNALING PROTEIN         
*EXPDTA    SOLUTION NMR                                                          
*NUMMDL    20                                                                    
*AUTHOR    J.HUBER,F.LOEHR,J.GRUBER,M.AKUTSU,P.GUENTERT,V.DOETSCH,V.V.ROGOV      
*REVDAT   1   01-MAY-19 6H8C    0                                                


Please acknowledge these references in publications where the data from this site have been utilized.

Contact the webmaster for help, if required. Wednesday, May 15, 2024 6:37:19 PM GMT (wattos1)